Advisory Board and Editors Immunology

PeerJ Factsheet
A one-page facts and stats PDF, to help when considering journal options with your co-authors.
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Rachel L. Allen

Head of the Graduate School at St George's, University of London.

Ruth Arnon

President of the Israel Academy of Sciences & Humanities. Former VP of the Weizmann Institute of Science. Significant contributions to vaccine development, cancer research & parasitic diseases. Has served as President of EFIS and Secretary-General of the IUIS. Awards include the Robert Koch Prize in Medical Sciences, Spain’s Diaz Memorial Prize, France's Legion of Honor, the Hadassah World Organization's Women of Distinction Award, the Wolf Prize for Medicine, the Rothschild Prize for Biology.

Nebojsa N Arsenijevic

Professor of Immunology and Basic Oncology; Center for Molecular Medicine and Stem Cells Research, Faculty of Medical Sciences, University of Kragujevac.

Vasco A Azevedo

Professor of Genetics and Deputy Head of the Department of Genetics, Ecology and Evolution. He is a member of the Brazilian Academy of Sciences and is a Knight of the National Order of Scientific Merit of the Brazilian Ministry of Science, Technology and Innovation. Researcher 1A of the National Council for Scientific and Technological Development (CNPq) which is the highest position.

Ramy K Aziz

I am a Professor and Chair, Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Egypt. I am interested in microbiome research, pharmacomicrobiomics, evolution and emergence microbial pathogenesis and resistance, microbial and phage genomics, antibiotic resistance surveillance, adaptive laboratory evolution, metabolic reconstruction and pathway gap filling, and virulence gene discovery.

Obul Reddy Bandapalli

PD. Dr.rer.nat. Obul R Bandapalli is a functional genomics researcher with special focus on transnational research. He is currently working at DKFZ, Heidelberg, Germany. He finished his habilitation in Molecular Medicine from the Molecular Medicine Partnership Unit of EMBL-University of Heidelberg and continues to teach at the University of Heidelberg. He has PhD in Molecular Biology from Humboldt University. Before moving to Germany he has worked at the Central Food Technological Research Institute Mysore, Dabur Research Foundation and Jawaharlal Nehru University, New Delhi, India. He obtained his Master´s in Biotechnology from Guru Ghasidas University and Bachelor’s in Sericulture from Sri Venkateswara University. Apart from research, he enjoys watching birds and nature trails.

Peter J. Barnes

Professor of Thoracic Medicine at the National Heart and Lung Institute, Head of Respiratory Medicine at Imperial College & Honorary Consultant Physician at Royal Brompton Hospital, London. Has been the most highly cited clinical scientist in Europe & the most highly cited respiratory researcher in the world over the last 20 years. Elected a Fellow of the Royal Society in 2007. Currently a member of the Scientific Committee of the WHO/NIH global guidelines on asthma (GINA) and COPD (GOLD).
Barnes is the author of over 1,000 publications in peer reviewed journals. He has edited or co-edited over 50 books on asthma, COPD and respiratory pharmacology.
He has been received honorary degrees from the Universities of Ferrara (Italy), Athens (Greece), Tampere (Finland), Leuven (Belgium) and Maastricht (Netherlands). He co-founded an Imperial spin-out company RespiVert, which was acquired by Johnson & Johnson and has developed novel inhaled treatments for COPD and severe asthma.

Jürgen C Becker

Prof. Becker is heading the Department of Translational Oncology at the Westdeutsches Tumorzentrum in Essen with a focus on skin cancer research.

Jürgen C. Becker received his medical degree from the Medical School Hannover for his work on the immune regulatory capacity of natural killer cells on the adaptive immune system. After finishing medical school he was first trained in Dermatology at the University of Würzburg and then as well in Tumor Immunology at the Scripps Research Institute, La Jolla, and the Danish Cancer Society, Copenhagen. For his characterization of the impact of therapeutic interventions on the adaptive immune responses against melanoma in preclinical models he received the PhD in Immunology. In 2003 he became full professor for Dermato-Oncology in Würzburg, where he coordinated a Clinical Research Group focusing on the tumor microenvironment. In 2010, he was appointed as director of General Dermatology at the Medical University of Graz. There, in parallel to his clinical duties, he successfully attracted the FP7 EU-project IMMOMEC (IMmune MOdulating strategies for treatment of MErkel cell Carcinoma, www.immomec.eu) and became deputy speaker of the graduate training program DK-MOLIN (Doktoratskolleg MOLecular fundamentals of INflammation, www.medunigraz.at/DK-MOLIN/).

Sander Bekeschus

Group leader and head of department of ZIK plasmatis "Plasma-Redox-Effects". Specialized on immunology, oncology, and tumor immunology.

Bruce A. Beutler

Regental Professor and Director of the Center for the Genetics of Host Defense at the UT Southwestern Medical Center in Dallas, Texas. Member of the National Academy of Sciences and the Institute of Medicine. Recipient of many awards, including the 2011 Nobel Prize for Medicine; the 2011 Shaw Prize; the 2009 Will Rogers Institute Annual Prize; the 2009 Albany Medical Center Prize; the 2007 Balzan Prize and the 2004 Robert Koch Prize. (Photo by Brian Coats for UT Southwestern Med Ctr)

Jeffrey A. Bluestone

A.W. and Mary Margaret Clausen Distinguished Professor and Director, Hormone Research Institute. Serves on the Science Translational Medicine advisory board and founding Director, Immune Tolerance Network. A recipient of a Guggenheim Fellowship and elected member of the Academy of Arts and Sciences and National Academy of Medicine. Dr. Bluestone has spent over 35 years working as an immunologist interested in immune tolerance as it relates to autoimmunity and organ transplantation.

Dominique Bonnet

Obtained her PhD degree in the University of Paris VII in 1993, and trained as a post-doc in Prof. John Dick’s group in Toronto. In 1998, she became Group Leader at the Coriell Institute for Medical Research and Assistant Professor, University of Medicine and Dentistry of New Jersey. In 2001, she joined the London Research Institute. Since 2002, she is also Professor, University College of London and Senior Lecturer at the Institute of Child Health.